U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 2C22H27N5O4.4ClH.H2O
Molecular Weight 1014.821
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LOSOXANTRONE HYDROCHLORIDE

SMILES

O.Cl.Cl.Cl.Cl.OCCNCCNC1=C2C3=C(C=C1)N(CCNCCO)N=C3C4=CC=CC(O)=C4C2=O.OCCNCCNC5=C6C7=C(C=C5)N(CCNCCO)N=C7C8=CC=CC(O)=C8C6=O

InChI

InChIKey=CNQCTSLNJJVSAU-UHFFFAOYSA-N
InChI=1S/2C22H27N5O4.4ClH.H2O/c2*28-12-9-23-6-7-25-15-4-5-16-20-19(15)22(31)18-14(2-1-3-17(18)30)21(20)26-27(16)11-8-24-10-13-29;;;;;/h2*1-5,23-25,28-30H,6-13H2;4*1H;1H2

HIDE SMILES / InChI

Molecular Formula C22H27N5O4
Molecular Weight 425.4809
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula H2O
Molecular Weight 18.0153
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Losoxantrone is an anthrapyrazole that induces both single and double strand breaks in DNA and is a potent inhibitor of DNA synthesis. The drug is in clinical trials for the treatment of breast cancer and of prostate cancer that is refractory to androgen ablation. Acute toxicity is negligible. Losoxantrone may be less cardiotoxic than doxorubicin. Up to 40% of patients encounter alopecia. 3% of patients develop congestive heart failure. Losoxantrone had been in phase II clinical trial for the treatment of breast and prostate cancer. However, this development was discontinued.

Approval Year

PubMed

PubMed

TitleDatePubMed
A structure-based 3D-QSAR study of anthrapyrazole analogues of the anticancer agents losoxantrone and piroxantrone.
2006-07-25
Structure-activity studies with cytotoxic anthrapyrazoles.
2006-06
The oxidative biotransformation of losoxantrone (CI-941).
2002-04
Phase I study of the combination of losoxantrone and cyclophosphamide in patients with refractory solid tumours.
2002-02-12
Separation methods for anthraquinone related anti-cancer drugs.
2001-11-25
Elimination pathways of [14C]losoxantrone in four cancer patients.
2001-02
DNA-interactive anticancer aza-anthrapyrazoles: biophysical and biochemical studies relevant to the mechanism of action.
2001-01
A novel 9-aza-anthrapyrazole effective against human prostatic carcinoma xenografts.
2001
A multicenter phase II trial of losoxantrone (DuP-941) in hormone-refractory metastatic prostate cancer.
2000-04
The displacement of iron(III) from its complexes with the anticancer drugs piroxantrone and losoxantrone by the hydrolyzed form of the cardioprotective agent dexrazoxane.
2000-01-22
Monotherapy of metastatic breast cancer: a review of newer agents.
1999
Patents

Patents

Sample Use Guides

In Vivo Use Guide
Sources: DOI: 10.1016/0959-8049(93)91029-K
Starting dose of 50 mg/m2 q3 weeks. Dose adjustments could be made anytime after the first dose
Route of Administration: Intravenous
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:15:45 GMT 2025
Edited
by admin
on Mon Mar 31 18:15:45 GMT 2025
Record UNII
W6E275IURX
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LOSOXANTRONE HYDROCHLORIDE
USAN  
USAN  
Official Name English
LOSOXANTRONE HYDROCHLORIDE HYDRATE
WHO-DD  
Preferred Name English
LOSOXANTRONE DIHYDROCHLORIDE HEMIHYDRATE
Common Name English
7-Hydroxy-2-[2-[(2-hydroxyethyl)amino]ethyl]-5-[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthra[1,9-cd]pyrazol-6(2H)-one, dihydrochloride, hemihydrate
Common Name English
LOSOXANTRONE HYDROCHLORIDE [USAN]
Common Name English
DUP-941
Code English
DUP 941
Code English
NSC-357885
Code English
CI-941
Code English
ANTHRA(1,9-CD)PYRAZOL-6(2H)-ONE, 7-HYDROXY-2-(2-((2-HYDROXYETHYL)AMINO)ETHYL)-5-((2-((2-HYDROXYETHYL)AMINO)ETHYL)AMINO)-, DIHYDROCHLORIDE, HYDRATE (2:1)
Common Name English
PD-113785
Code English
Losoxantrone hydrochloride hydrate [WHO-DD]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C2107
Created by admin on Mon Mar 31 18:15:46 GMT 2025 , Edited by admin on Mon Mar 31 18:15:46 GMT 2025
Code System Code Type Description
USAN
DD-76
Created by admin on Mon Mar 31 18:15:46 GMT 2025 , Edited by admin on Mon Mar 31 18:15:46 GMT 2025
PRIMARY
FDA UNII
W6E275IURX
Created by admin on Mon Mar 31 18:15:46 GMT 2025 , Edited by admin on Mon Mar 31 18:15:46 GMT 2025
PRIMARY
NCI_THESAURUS
C72077
Created by admin on Mon Mar 31 18:15:46 GMT 2025 , Edited by admin on Mon Mar 31 18:15:46 GMT 2025
PRIMARY
ChEMBL
CHEMBL83520
Created by admin on Mon Mar 31 18:15:46 GMT 2025 , Edited by admin on Mon Mar 31 18:15:46 GMT 2025
PRIMARY
PUBCHEM
166541
Created by admin on Mon Mar 31 18:15:46 GMT 2025 , Edited by admin on Mon Mar 31 18:15:46 GMT 2025
PRIMARY
EPA CompTox
DTXSID70157873
Created by admin on Mon Mar 31 18:15:46 GMT 2025 , Edited by admin on Mon Mar 31 18:15:46 GMT 2025
PRIMARY
NSC
357885
Created by admin on Mon Mar 31 18:15:46 GMT 2025 , Edited by admin on Mon Mar 31 18:15:46 GMT 2025
PRIMARY
CAS
132937-89-4
Created by admin on Mon Mar 31 18:15:46 GMT 2025 , Edited by admin on Mon Mar 31 18:15:46 GMT 2025
PRIMARY
EVMPD
SUB02975MIG
Created by admin on Mon Mar 31 18:15:46 GMT 2025 , Edited by admin on Mon Mar 31 18:15:46 GMT 2025
PRIMARY
Related Record Type Details
ANHYDROUS->SOLVATE
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY